XETRA - Delayed Quote EUR

LIMES Schlosskliniken AG (LIK.DE)

Compare
342.00
+6.00
+(1.79%)
At close: January 3 at 5:36:06 PM GMT+1
Loading Chart for LIK.DE
DELL
  • Previous Close 336.00
  • Open 344.00
  • Bid 338.00 x --
  • Ask 346.00 x --
  • Day's Range 342.00 - 344.00
  • 52 Week Range 274.00 - 390.00
  • Volume 3
  • Avg. Volume 34
  • Market Cap (intraday) 100.272M
  • Beta (5Y Monthly) 0.48
  • PE Ratio (TTM) 23.47
  • EPS (TTM) 14.57
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 641.00

LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, and Liechtenstein. It focuses on the treatment of stress-related illnesses, and mental and psychological disorders, such as depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, personality disorder, chronic pain, burnout, psychoses, obsessive compulsive disorder, sleep disorder, somatoform disorder, and sports psychiatry. The company was formerly known as GMF Capital AG and changed its name to LIMES Schlosskliniken AG in December 2005. The company was founded in 2005 and is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of G M F Capital GmbH.

www.limes-schlosskliniken.de

210

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LIK.DE

View More

Performance Overview: LIK.DE

Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

LIK.DE
3.64%
DAX P
0.02%

1-Year Return

LIK.DE
21.28%
DAX P
18.71%

3-Year Return

LIK.DE
66.02%
DAX P
25.31%

5-Year Return

LIK.DE
280.00%
DAX P
48.71%

Compare To: LIK.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LIK.DE

View More

Valuation Measures

As of 1/3/2025
  • Market Cap

    96.17M

  • Enterprise Value

    97.01M

  • Trailing P/E

    23.46

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.40

  • Price/Book (mrq)

    5.96

  • Enterprise Value/Revenue

    2.36

  • Enterprise Value/EBITDA

    66.09

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.23%

  • Return on Assets (ttm)

    11.34%

  • Return on Equity (ttm)

    27.91%

  • Revenue (ttm)

    41.78M

  • Net Income Avi to Common (ttm)

    4.27M

  • Diluted EPS (ttm)

    14.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.83M

  • Total Debt/Equity (mrq)

    47.31%

  • Levered Free Cash Flow (ttm)

    -1.7M

Research Analysis: LIK.DE

View More

People Also Watch